A new form of CAR T kills leukemia, multiple myeloma, and sarcoma in mice, opening the door to a future off-the-shelf cancer treatment without chemotherapy.

A new immunotherapy drug has demonstrated early promise in a recent prostate cancer clinical trial. The drug, called VIR-5500, is a "masked T-cell engager." This type of immunotherapy ignites our own ...

Ziyafetova, G. (2026) Complete Response in Inoperable Stage IIB Squamous Cell Lung Carcinoma after Sequential Radiotherapy ...

Trish Prosser said she was too embarrassed to tell loved ones about the type of cancer she had as she felt there was a stigma ...

Imaging studies of more than 27,000 adults link a healthier thymus on CT scans with a longer life and lower risks of ...

After doctors told him he had just two to three years to live, a South Carolina father turned to Duke Health for a second opinion and enrolled in an experimental cancer trial. Now, nearly all of his ...

White House Chief of Staff Susie Wiles has been diagnosed with early-stage breast cancer. Here’s what to know about symptoms, ...

Prostate-specific membrane androgen PET/CT can help clinicians intensify or de-escalate care for men with prostate cancer who have biochemical recurrence following radical prostatectomy.A ...

Pressurized oxygen is proven to help the body heal faster. Now it’s being touted for reversing aging, boosting your brain and ...

Stanford Medicine pediatric hematologist Agnieszka Czechowicz, MD, Ph.D., has devoted her research career to improving ...

Radiation therapy treats roughly two-thirds of all cancer patients, yet healthy tissue has always absorbed collateral damage during treatment. A new generation of ultra-fast radiation delivery, ...